Yiyuan Biotech Officially Launches in Zhuhai, Pioneering Synthetic Biology Solutions for Sustainable Aquaculture

On the morning of March 31, 2026, the launch ceremony of Zhuhai Yiyuan Biotechnology Co., Ltd. was grandly held at Gecreate Digital Valley in the High-Tech Zone of Zhuhai City. The holding of this ceremony,Marking the Official Establishment of Yiyuan Biotechnology in Zhuhai High-Tech Industrial Development Zone, with synthetic biology technology as the core,Deeply Engaged in the Field of Biomanufacturing for Aquaculture, injecting new momentum into the development of the regional biopharmaceutical industry and the green upgrading of aquaculture. Leaders from the Zhuhai Municipal Science and Technology Innovation Bureau, the Ocean Development Bureau, and relevant departments of the High-Tech Zone, along with representatives from industry-academia-research-capital partners including the Fudan-Zhuhai Innovation Research Institute, Zhuhai High-Tech Financial Investment, Honghui Fund, and Yikolai Biotechnology, attended the ceremony to jointly witness this significant moment.

Yiyuan Biotech Officially Establishes Presence in Zhuhai High-Tech Industrial Development Zone

At the outset of the ceremony, Wang Xinyuan, CEO of Yiyuan Biotechnology, extended a warm welcome and heartfelt gratitude to the distinguished leaders and guests in attendance. He stated that the establishment of Yiyuan Biotechnology represents a significant strategic move for the company’s development and marks a new starting point for deepening collaboration with the Zhuhai High-Tech Industrial Development Zone in the synthetic biology industry. In the presence of all attendees, Ye Aijun, Deputy Dean of the Fudan-Zhuhai Innovation Research Institute; Gou Tongjun, Chairman of Zhuhai High-Tech Financial Investment; Yan Jingran, Investment Director at Honghui Capital; Wang Shu, Vice President of Yikelai Biotechnology; and Lv Hong, Chairman of Yiyuan Biotechnology, jointly took the stage. Yan Jingran officially announced the commencement of the launch ceremony for Yiyuan Biotechnology’s establishment and delivered remarks, expressing high hopes for the company’s future development. He emphasized the expectation that the company would prioritize technological innovation to achieve high-quality growth within the Zhuhai High-Tech Industrial Development Zone.

Professor Lü Hong, Fudan University

As the core leader of Yiyuan Bio, Professor Lu Hong, Chairman of the Company and Level-2 Professor at the School of Life Sciences, Fudan University, provided a detailed introduction to the company’s development history, core business and technological advantages, as well as the background and profound significance of its establishment in the Zhuhai High-Tech Industrial Development Zone. It was reported that Yiyuan Bio has strategically integrated the industrial resources of Yikelai Biotechnology.Leveraging the patented synthetic biology strains of *Kluyveromyces marxianus* from Fudan University (Zhuhai Research Institute), to build“Cell Factory”Core Technology System, Key DevelopmentFunctional Feed Ingredients, Aquaculture ImmunostimulantsThese products aim to replace traditional fishmeal and antibiotics through biomanufacturing pathways, facilitating the realization of "antibiotic-free aquaculture." Its core product, KM-Virus-Like Particles (VLPs), achieves a protection rate of over 80%, while yeast immune-enhancement technology boosts the disease resistance of fish and shrimp by more than 30%. Additionally, it effectively mitigates the hazards of environmental toxins in aquaculture settings, aligning with national development directions for green aquaculture and marine ranching construction.

Currently, Yiyuan Bio has establishedCentered on Fudan University's Technical TeamThe R&D team comprises two professors, one senior researcher, and multiple master’s and doctoral degree holders. The company plans to build a master’s-level R&D team of at least ten members within the next three years. It has leased 1,200 square meters of space in Gechuang Digital Valley to establish an integrated innovation platform for R&D, testing, and validation, providing robust support for the industrialization of its technologies.

In his address, Shan Jinghui, Party Group Member and Deputy Director of the Zhuhai Municipal Science and Technology Innovation Bureau, stated that the biopharmaceutical industry is a national strategic emerging industry and one of the core industries prioritized for cultivation and development in the Zhuhai National High-Tech Industrial Development Zone. Yiyuan Biotechnology empowers aquaculture with synthetic biology technology, aligning precisely with the zone’s strategic layout for the integrated development of the marine economy and the biopharmaceutical industry. The High-Tech Zone will continue to provide policy and resource support, offering comprehensive services to facilitate the company’s rapid growth into a benchmark enterprise in its niche sector.

Ye Aijun, Deputy Dean of the Fudan University Zhuhai Innovation Research Institute, pointed out that Yiyuan Bio serves as a model for the deep integration of industry, academia, and research. The Institute will continue to leverage its technological and talent advantages to safeguard the company’s technological innovation and achievement commercialization, thereby facilitating the establishment and successful development of more university-led innovations in the Zhuhai High-Tech Industrial Development Zone.

Ye Aijun, Deputy Dean of the Fudan University Zhuhai Innovation Research Institute

Following the launch ceremony, attending leaders and guests, guided by Duan Jinkun, Technical Director of Yiyuan Biotechnology, toured the company’s Future Validation Platform site. They gained a detailed understanding of the site’s functional layout, supporting facilities, and future usage plans, thereby gaining an intuitive appreciation of Yiyuan Biotechnology’s clear strategic layout in technological R&D and industrial implementation.

Zhuhai High-Tech Industrial Development Zone asThe Guangdong-Hong Kong-Macao Greater Bay Area: A Highland for Biopharmaceutical InnovationIn recent years, it has continuously focused on the fields of innovative biological drugs and high-end medical devices, introducing policies such as the "Ten Measures for Promoting High-Quality Development of the Biopharmaceutical and Big Health Industries in Zhuhai High-Tech Zone," establishing a full-chain industrial support system, and achieving simultaneous leaps in industrial scale and innovation capacity. The establishment of Yiyuan Biology not only fills the gap in regional synthetic biology empowermentMarket Gaps in the Aquaculture Industry, further enriching the ecological layout of the biopharmaceutical industry in the High-Tech Zone and providing critical biotechnological support for the localization and sustainable development of the aquaculture supply chain.

In the future, Yiyuan Bio will leverage the policy, geographic, and industrial ecosystem advantages of the Zhuhai High-Tech Industrial Development Zone to continuously deepen its R&D in core synthetic biology technologies and their industrial applications, accelerating the advancement ofFunctional feed ingredients, aquaculture immunoprophylactic agents, and other productsR&D and market implementation, creating a replicable“Yeast + Aquaculture”Green Development Plan. Meanwhile, the company will deepen its collaboration with universities, research institutes, and industry partners to drive the upgrading of the aquaculture industry through technological innovation. This effort will contribute to the high-quality development of Zhuhai’s marine economy and the construction of national green agriculture, while also injecting new vitality into Zhuhai High-Tech Industrial Development Zone’s endeavor to create an industrial model for the integrated development of biopharmaceuticals and the marine economy.